Table 1.
Baseline and treatment variables in anemic and non-anemic patient groups
| Anemic | Non-anemic | P value | ||
|---|---|---|---|---|
| Age (years) |
61 (41-82) |
60 (45-83) |
0.796 |
|
| Male:female |
27:3 |
64:9 |
0.738 |
|
| Hemoglobin (g/dl) |
Male |
11.4 (8.6-11.9) |
13.95 (12.0-15.8) |
0.000 |
| Female |
10.3 (8.1-10.8) |
13.1 (11.7-14.6) |
0.000 |
|
| Tumor location |
Cervical |
5 |
8 |
0.548 |
| Upper |
7 |
14 |
||
| Middle |
11 |
38 |
||
| Low |
7 |
13 |
||
| Treatment modality |
Radiotherapy |
11 |
21 |
0.519 |
| Surgery + radiotherapy |
9 |
31 |
||
| Chemoradiotherapy |
5 |
7 |
||
| Surgery + Chemoradiotherapy |
5 |
14 |
||
| TNM stage |
I |
3 |
4 |
0.296 |
| II |
13 |
31 |
||
| III |
11 |
36 |
||
| IV |
3 |
2 |
||
| T stage |
T1 |
3 |
8 |
0.155 |
| T2 |
9 |
13 |
||
| T3 |
17 |
38 |
||
| T4 |
1 |
14 |
||
| Status of lymph nodes |
Negative |
11 |
34 |
0.390 |
| Positive |
19 |
39 |
||
| Values are shown as median (range) or number, as appropriate. | ||||